Mehmet Erman ERDEMLİ, Harika Gözde GÖZÜKARA BAĞ, Zeynep ERDEMLİ, Eyüp ALTINÖZ

The role of Crocin in an acrylamide-induced neurotoxicity model in Wistar rats

Aim: The changes in rat brain tissues treated with Crocin (Cr) as a protective agent in an acrylamide (AA) neurotoxicity model wereinvestigated.Material and Methods: The present with of the experimental animal ethics committee at Inonu University, Faculty of Medicine (2016/ A-59). Forty male rats were randomly divided into 4 groups with study was conducted the approval equal number of rats (10):Control, Cr, AA, Cr + AA Groups. Malondialdehyde (MDA), reduced glutathione (GSH), total antioxidant status (TAS), total oxidantstatus (TOS), Oxidative stress index (OSI), superoxide dismutase (SOD), catalase (CAT) and protein values were examined in thebrain tissues.Results: MDA, TOS and OSI levels increased in brain tissues of AA administered rats when compared to the other groups, whilethe GSH, TAS, SOD and CAT levels decreased in the group (p < 0.05). GSH, TAS, SOD and CAT levels increased, but MDA, TOS andOSI levels decreased in the AA + Cr administered group when compared to the AA group (p < 0.05). It was observed that oral AAadministration altered the antioxidant/oxidant balance favoring the oxidants in male rat brain tissues, leading to oxidative stressinduced neurotoxicity, while Cr administration reestablished the normal antioxidant/oxidant balance, preventing the oxidative stressinduced neurotoxicity via detoxification.Conclusion: The present study concluded that the administered Cr dose was sufficient to prevent neurotoxicity and we recommendthat adequate amounts of Cr should be consumed to prevent AA-induced toxicity and improve antioxidant capacity.

PDF

___

1. Exon JH. A review of the toxicology of acrylamide: J Toxicol Environ Health B Crit Rev. 2006;9:397–412.
2. Nordin AM, Walum E, Kjellstrand P, et al. Acrylamide – inducedd effects on general and neurospecific cellular functions during exposure and recovery. Cell Biol Toxicol 2003;19:43-51.
3. Tareke E, Rydberg P, Karlsson P et al. Analysis of acrylamide, a carcinogen formed in heated food stuffs. J Agric Food Chem 2002;50:4998–5006.
4. Sickles D, Goldstein B. Acrylamide produces a direct, dose-dependent and specific inhibition of oxidative metabolism in motoneurons. Neurotoxicol 1985;7:187–95.
5. LoPachin RM. The changing view of acrylamide neurotoxicity. Neurotoxicol 2004;25:617–30.
6. Miller MS, Spencer PS. The mechanisms of acrylamide axonopathy. Annu Rev Pharmacol Toxicol 1985;25:643–66.
7. He Y, Tan D, Bai B et al. Epigallocatechin-3- gallateattenuates acrylamide-induced apoptosis and astrogliosis in rat cerebral cortex. Toxicol Mech Methods 2017; 27:298–306.
8. Lai SM, Gu ZT, Zhao MM, et al. Toxic effect of acrylamide on the development of hippocampal neurons of weaning rats. Neural Regen Res 2017; 12:1648-54.
9. Pan X, Zhu L, Lu H et al. Melatonin attenuates oxidative damage induced by acrylamide in vitro and in vivo. Oxid Med Cell Longev 2015;2015:703-9.
10. Pan X, Wu X, Yan D et al. Acrylamide-induced oxidative stress and inflammatory response are alleviated by N-acetylcysteine in PC12 cells: involvement of the crosstalk between Nrf2 and NF-kappaB pathways regulated by MAPKs. Toxicol Lett 2018;288:55-64.
11. Srivastava R, Ahmed H, Dixit RK et al. Dharamveer SSA Crocus sativus L.: a comprehensive review. Pharmacogn Rev 2010;4:200-8.
12. Hosseinzadeh H, Shamsaie F, Mehri S. Antioxidant activity of aqueous and ethanolic extracts of Crocus sativus L. stigma and its bioactive constituents, crocin and safranal. Pharmacogn Mag 2009;5:419-24.
13. Christodoulou E, Kadoglou NP, Kostomitsopoulos N et al. Saffron: a natural product with potential pharmaceutical applications. J Pharm Pharmacol 2015;67:1634-49.
14. Karimi E, Oskoueian E, Hendra R et al. Evaluation of Crocus sativus L. Stigma phenolic and flavonoid compounds and its antioxidant activity. Molecules 2010;15:6244–56.
15. Mashmoul M, Azlan A, Khaza’ai H et al. Saffron: a natural potent antioxidant as a promising antiobesity drug. Antioxidants 2013;2:293-308.
16. Hosseinzadeh H, Noraei NB. Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res 2009;23:768-74.
17. Hosseinzadeh H, Nassiri-Asl M. Avicenna’s (Ibn Sina) the canon of medicine and saffron (Crocus sativus): a review. Phytother Res 2013;27:475-83.
18. Hosseinzadeh H, Sadeghnia HR. Effect of safranal, a constituent of Crocus sativus (saffron), on methyl methanesulfonate (MMS)-induced DNA damage in mouse organs: an alkaline single-cell gel Metab Brain Dis electrophoresis (comet) assay. DNA Cell Biol 2007;26:841-6.
19. Uchiyama M, Mihara M. Determination of MDA precursor in tissue by TBA test. Anal Biochem 1978; 36:271-8.
20. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1979;95:351-8.
21. Jolitha AB, Subramanyam MV, Devi SA. Modification by vitamin E and exercise of oxidative stress in regions of aging rat brain: studies on superoxide dismutase isoenzymes and protein oxidation status. Exp Gerontol 2006; 41:753-63.
22. Aebi H. Methods of enzymatic analysis. Academic Press, New York and London 1974; 673–7.
23. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11.
24. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-85.
25. A. Besaratinia, G.P. Pfeifer, A review of mechanisms of acrylamide carcinogenicity, Carcinogenesis 2007;3: 519-28.
26. Halliwell B, Gutteridge JM. Free Radicals in Biology and Medicine, Oxford University Press, USA 2015.
27. Makhlouf H, Saksouk M, Habib J et al. Determination of antioxidant activity of saffron taken from the flower of Crocus sativus grown in Lebanon. Afr J Biotechnol 2011;41:8093-100.
28. Bansal AK, Bansal M, Soni G et al. Protective role of Vitamin E pretreatment on N-nitrosodiethylamine induced oxidative stress in rat liver. Chem Biol Interact 2005;156:101–11.
29. Zhu R, Wang Y, Zhang L et al. Oxidative stress and liver disease. Hepatol Res 2012;42:741–9.
30. He J, Huang B, Ban X et al. In vitro and in vivo antioxidant activity of the ethanolic extract from Meconopsis quintuplinervia, J Ethnopharmacol 2012; 141:104-10.
31. Erdemli ME, Aladag MA, Altinoz E et al. Acrylamide applied during pregnancy causes the neurotoxic effect by lowering BDNF levels in the fetal brain. Neurotoxicol Teratol 2018;67:37-43.
32. Erdemli ME, Turkoz Y, Altinoz E et al. Investigation of the effects of acrylamide applied during pregnancy on fetal brain development in rats and protective role of the vitamin E. Hum Exp Toxicol 2016;35:1337–44.
33. Goudarzi M, Mombeini MA, Fatemi I et al. Neuroprotective effects of Ellagic acid against acrylamide-induced neurotoxicity in rats. Neurol Res 2019;41:419–28.
34. Tabeshpour J, Mehri S, Abnous K et al. Neuroprotective Effects of Thymoquinone in Acrylamide-Induced Peripheral Nervous System Toxicity Through MAPKinase and Apoptosis Pathways in Rat. Neurochem Res 2019;44:1101–12.
35. Mehri S, Abnous K, Khooei A et al. Crocin reduced acrylamide-induced neurotoxicity in Wistar rat through inhibition of oxidative stress. Iran J Basic Med Sci 2015;18:902-8.
36. Rao SV, Hemalatha P, Yetish S et al. Prophylactic neuroprotective propensity of Crocin, a carotenoid against rotenone induced neurotoxicity in mice: behavioural and biochemical evidence. Metab Brain Dis 2019;34:1341-53.
37. Shafahi M, Vaezi G, Shajiee H et al. Crocin Inhibits Apoptosis and Astrogliosis of Hippocampus Neurons Against Methamphetamine Neurotoxicity via Antioxidant and Antiinflammatory Mechanisms. Neurochem Res 2018;43:2252-9.